Package Leaflet: Information for the User
Rivaroxaban Sun 10 mg film-coated tablets EFG
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
Rivaroxaban Sun contains the active substance rivaroxaban and is used in adults for:
Rivaroxaban Sun belongs to a group of medicines called antithrombotic agents. It works by blocking a factor involved in blood clotting (factor Xa) and thus reducing the tendency of blood to form clots.
Do not take Rivaroxaban Sun
Do not take Rivaroxaban and inform your doctorif any of these circumstances apply to you.
Warnings and precautions
Consult your doctor or pharmacist before starting to take rivaroxaban.
Be careful with Rivaroxaban
or tumors located in the stomach, intestines, genital tract, or urinary tract
Tell your doctorif you have any of these situationsbefore taking rivaroxaban. Your doctor will decide if you should be treated with this medication and if you should be kept under closer observation.
If you need surgery:
Children and adolescents
Rivaroxaban Sun 10 mg film-coated tablets are not recommended for children under 18 years of age.There is not enough information about their use in children and adolescents.
Other medications and Rivaroxaban
Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medication, including those obtained without a prescription.
If any of the above circumstances apply to you,tell your doctorbefore taking rivaroxaban, as the effect of rivaroxaban may be increased. Your doctor will decide if you should be treated with this medication and if you should be kept under closer observation.
If your doctor considers that you have a higher risk of developing a stomach or intestinal ulcer, they may recommend using a preventive treatment in addition.
any medication for the treatment of epilepsy (phenytoin, carbamazepine, phenobarbital)
St. John's Wort (Hypericum perforatum), a herbal remedy for the treatment of depression
rifampicin, an antibiotic
If any of the above circumstances apply to you,tell your doctorbefore taking rivaroxaban, as the effect of rivaroxaban may be reduced. Your doctor will decide if you should be treated with rivaroxaban and if you should be kept under closer observation.
Pregnancy and breastfeeding
Do not take rivaroxaban if you are pregnant or breastfeeding. If there is any possibility that you may become pregnant, use a reliable contraceptive while taking rivaroxaban. If you become pregnant while taking this medication, inform your doctor immediately, who will decide how you should be treated.
Driving and using machines
Rivaroxaban may cause dizziness (frequent side effect) or fainting (uncommon side effect) (see section 4, "Possible side effects"). You should not drive, ride a bicycle, or use tools or machines if you are affected by these symptoms.
Rivaroxaban contains lactose and
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
This medication contains less than 23 mg of sodium (1 mmol) per film-coated tablet; this is essentially "sodium-free".
Follow the instructions for administration of this medication exactly as indicated by your doctor. If in doubt, consult your doctor or pharmacist again.
What dose to take
The recommended dose is one 10 mg rivaroxaban tablet once a day.
After at least 6 months of treatment for blood clots, the recommended dose is one 10 mg tablet once a day or one 20 mg tablet once a day. Your doctor has prescribed rivaroxaban 10 mg once a day.
Swallow the tablet, preferably with water.
Rivaroxaban can be taken with or without food.
If you have difficulty swallowing the whole tablet, consult your doctor about other ways to take rivaroxaban. The tablet can be crushed and mixed with water or apple puree, immediately before taking it.
If necessary, your doctor may also administer the crushed rivaroxaban tablet through a gastric tube.
When to take Rivaroxaban Sun
Take one tablet every day, until your doctor tells you to stop.
Try to take one tablet at the same time every day, to help you remember.
Your doctor will decide how long you should continue taking the treatment.
To prevent the formation of blood clots in the veins after hip or knee replacement surgery:
Take the first tablet 6 to 10 hours after the operation.
If you have undergone major hip surgery, you will usually take tablets for 5 weeks.
If you have undergone major knee surgery, you will usually take tablets for 2 weeks.
If you take more Rivaroxaban Sun than you should
If you have taken more rivaroxaban than you should, inform your doctor immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount taken.
Taking too much rivaroxaban increases the risk of bleeding.
If you forget to take Rivaroxaban Sun
If you forget to take a dose, take it as soon as you remember. Take the next tablet the next day and, after that, take one tablet every day, as usual.
Do not take a double dose to make up for forgotten doses.
If you stop taking Rivaroxaban Sun
Do not stop taking rivaroxaban without talking to your doctor first, as rivaroxaban prevents the development of a serious condition.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, rivaroxaban can cause side effects, although not everyone gets them.
Like other similar medications (antithrombotics), rivaroxaban can cause bleeding, which can be life-threatening. Excessive bleeding can cause a sudden drop in blood pressure (shock). In some cases, the bleeding may not be visible.
Tell your doctor immediately if you experience any of the following side effects:
Your doctor will decide whether to keep you under closer observation or change your treatment.
The frequency of these side effects is very rare (up to 1 in 10,000 people).
The frequency of severe allergic reactions is very rare (anaphylactic reactions, including anaphylactic shock; may affect up to 1 in 10,000 people) and uncommon (angioedema and allergic edema; may affect up to 1 in 100 people).
General list of possible side effects:
Frequent(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Very rare(may affect up to 1 in 10,000 people)
Frequency not known(cannot be estimated from available data):
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the packaging and on each blister, after "EXP". The expiry date is the last day of the month indicated.
This medicine does not require any special storage conditions.
Crushed tablets
Crushed tablets are stable in water or apple puree for up to 4 hours.
Medicines should not be disposed of via wastewater or household waste. Dispose of the packaging and any unused medicine in the SIGRE collection point at your pharmacy. Ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Tablet core: microcrystalline cellulose (E460), hypromellose 2910 (E464), lactose monohydrate, low-substituted hydroxypropylcellulose (E463), sodium croscarmellose (E486), sodium lauryl sulfate (E487), magnesium stearate (E572).
Tablet film coating: hypromellose 2910 (E464), lactose monohydrate, macrogol 4000 (E1521), titanium dioxide (E 171), yellow iron oxide (E 172), and carmine (E120).
See section 2 "Rivaroxaban Sun contains lactose and sodium.
Appearance and packaging of the product
Rivaroxaban Sun 10 mg film-coated tablets are pink, round, 6 mm in diameter, and have "?" engraved on one side and "10" on the other.
Rivaroxaban Sun 10 mg film-coated tablets are packaged in transparent PVC/PVDC/Al blisters, in aluminum foil, in boxes of 5, 10, 28, 30, 98, and 100 tablets.
Not all pack sizes may be marketed.
Marketing authorization holder
Sun Pharmaceutical Industries Europe B.V.
Polarisavenue 87
2132JH Hoofddorp
Netherlands
Manufacturer
Sun Pharmaceutical Industries Europe B.V.
Polarisavenue 87
2132JH Hoofddorp
Netherlands
or
Terapia S.A. Strada Fabricii Nr. 124, Cluj-Napoca, Jud. Cluj, 400632, Romania |
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Sun Pharma Laboratories, S.L. Rambla de Catalunya 53-55 08007 Barcelona Spain Tel: +34-93-3427890 |
Date of the last revision of this leaflet:March 2024
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/